1-20 of 33
Authors: Daniela Lötsch
Journal Article
Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens
Neuro-Oncology, Volume 27, Issue 3, March 2025, Pages 811–827, https://doi.org/10.1093/neuonc/noae228
Published: 18 November 2024
Journal Article
STEM-11. MULTIDIMENSIONAL PROFILING OF TUMOR CELL HETEROGENEITY REVEALS CELL-LINEAGE SPECIFIC FUNCTIONS IN SUPRATENTORIAL EPENDYMOMAS
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii60, https://doi.org/10.1093/neuonc/noae165.0237
Published: 11 November 2024
Journal Article
HGG-15. SYNERGISTIC EFFECTS OF COMBINED MEK/CDK4/6 INHIBITOR TREATMENT ON BRAFV600E POSITIVE HIGH-GRADE GLIOMA
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.299
Published: 18 June 2024
Journal Article
EPEN-12. EZHIP IMPACTS CELLULAR DIFFERENTIATION IN POSTERIOR FOSSA GROUP A EPENDYMOMA
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.214
Published: 18 June 2024
Journal Article
EPEN-07. USP7 IS AN INTERACTION PARTNER OF EZHIP AND POTENTIAL DRUGGABLE TARGET IN PFA EPENDYMOMAS
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.209
Published: 18 June 2024
Journal Article
ETMR-19.BCOR/L1-ALTERATIONS REWIRE HISTONE REGULATION TO INDUCE ONCOGENIC PATHWAYS IN PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.189
Published: 18 June 2024
Journal Article
PATH-08. PRE-OPERATIVE TUMOUR CLASSIFICATION USING NANOPORE SEQUENCING OF CEREBROSPINAL FLUID
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.711
Published: 18 June 2024
Journal Article
NFS-20. DECIPHERING CELLULAR CROSSTALK IN PERIPHERAL NERVOUS SYSTEM TUMORS ASSOCIATED WITH NEUROFIBROMATOSIS TYPE 1 THROUGH SINGLE-CELL RNA SEQUENCING
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.578
Published: 18 June 2024
Journal Article
ATRT-12. EXPLORING FGFR INHIBITION AND COMBINATION THERAPIES FOR ATYPICAL TERATOID/RHABDOID TUMORS
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.012
Published: 18 June 2024
Journal Article
ATRT-10. SINGLE-CELL TRANSCRIPTOME ANALYSIS REVEALS CELLULAR HIERARCHIES AND THERAPEUTIC VULNERABILITIES OF ETMR
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i3, https://doi.org/10.1093/neuonc/noad073.010
Published: 12 June 2023
Journal Article
HGG-19. CLINICAL RESPONSE TO THE PDGFRA/KIT INHIBITOR AVAPRITINIB IN PEDIATRIC AND YOUNG ADULT HIGH-GRADE GLIOMA PATIENTS WITH H3K27M OR PDGFRA GENOMIC ALTERATIONS
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Pages i43–i44, https://doi.org/10.1093/neuonc/noad073.168
Published: 12 June 2023
Journal Article
HGG-08. COMBINATORIAL ACTIVITY OF CDK4/6-INHIBITORS AND TRAMETINIB IN PEDIATRIC HIGH-GRADE GLIOMA WITH BRAFV600E MUTATION AND HOMOZYGOUS CDKN2A DELETION
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i40, https://doi.org/10.1093/neuonc/noad073.157
Published: 12 June 2023
Journal Article
ATRT-07. CLINICAL APPLICABILITY OF C19MC MIRNA DETECTION IN LIQUID BIOPSIES OF ETMR PATIENTS
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i2, https://doi.org/10.1093/neuonc/noad073.007
Published: 12 June 2023
Journal Article
EPEN-11. CHARACTERIZATION OF THE SPATIAL ARCHITECTURE OF INTRATUMORAL CELL STATES IN PEDIATRIC HIGH-RISK EPENDYMOMA
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i29, https://doi.org/10.1093/neuonc/noad073.115
Published: 12 June 2023
Journal Article
DDDR-22. TRANSLATION OF THE PDGFRA/KIT INHIBITOR AVAPRITINIB FOR PEDIATRIC HIGH-GRADE GLIOMA
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii103, https://doi.org/10.1093/neuonc/noac209.387
Published: 14 November 2022
Journal Article
PATH-09. Liquid biopsy of cerebrospinal fluid enables detecting and monitoring ofMYC/MYCN amplification in pediatric CNS malignancies
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i160, https://doi.org/10.1093/neuonc/noac079.593
Published: 03 June 2022
Journal Article
MODL-14 Inhibition of cell cycle mechanisms to combat high-risk medulloblastoma
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i171, https://doi.org/10.1093/neuonc/noac079.637
Published: 03 June 2022
Journal Article
ETMR-12. Novel cell models of CNS tumors with BCOR fusion or internal tandem duplication suggest FGFR and PDGFR as promising therapy targets
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i52, https://doi.org/10.1093/neuonc/noac079.190
Published: 03 June 2022
Journal Article
ETMR-11. Transcriptional changes upon knockdown of alteredBCOR/BCORL1 transcripts in preclinical models of CNS embryonal tumors with BCOR-related alterations
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i51–i52, https://doi.org/10.1093/neuonc/noac079.189
Published: 03 June 2022
Journal Article
CSIG-04. UNCOUPLING OF ETS1 FROM MAPK PATHWAY SIGNALS AS RESISTANCE MECHANISM TOWARDS BRAF INHIBITORS IN BRAF-MUTATED CHILDHOOD GLIOMA
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi33–vi34, https://doi.org/10.1093/neuonc/noab196.130
Published: 12 November 2021
